The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people
hospitalized with severe COVID-19 illness has engendered considerable interest in the …

Introduction To date, COVID‐19 has claimed 4.9 million lives. Diabetes has been identified
as an independent risk factor of serious outcomes in people with COVID‐19 infection …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

Background. Although vaccine rollout for COVID‐19 has been effective in some countries,
there is still an urgent need to reduce disease transmission and severity. We recently carried …

Results The final selected studies (n= 24 studies; 32,715 patients) showed significant
reductions in ICU admission (OR= 0.78, 95% CI: 0.58–1.06; n= 10; I 2= 58.5%) and death …

Objectives There is conflicting evidence about the efficacy of statin use in regard to clinical
outcomes in patients with coronavirus disease 2019 (COVID-19). A systematic review and …

Background Statins have anti-inflammatory and immunomodulatory effects that may reduce
the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is …

Background and aims The idea of treating COVID-19 with statins is biologically plausible,
although it is still controversial. The systematic review and meta-analysis aimed to address …

Purpose Observations studies have shown that prior use of statins is associated with a
reduced risk of adverse clinical outcomes in patients with COVID-19. However, the available …